Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
4
×
boston blog main
boston
boston top stories
clinical trials
new york top stories
startups
alirocumab
alnylam pharmaceuticals
amgen
aphelion capital
azacitidine
beta-thalassemia
biolinq
cancer
codiak biosciences
continuous glucose monitoring
cutaneous t-cell lymphoma
dacogen
deals
decitabine
diabetes
dna
drugs
epigenetics
epizyme
evercore isi
evolocumab
exosome
farydak
flagship pioneering
fulcrum therapeutics
heart attack
hikma
inclisiran
insulated genomic domains
jared tagney
What
based
4
×
new
4
×
medicines
million
research
startup
adds
advance
aims
alnylam
approach
begin
biolinq
biosciences
biosensor
biotech
bio’s
brings
bubbles
called
cells
cholesterol
class
clinical
codiak
data
debuts
developing
diabetes
drug
drugs
epigenetic
epigenetics
evidence
exosome
exosomes
field
flagship’s
formed
fund
Language
unset
Current search:
new
×
based
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
